| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016918 |
| Receipt No. | R000019637 |
| Official scientific title of the study | Feasibility study about supportive therapy with elemental diet, "elental", for chemotherapy induced oral mucositis in patients with gastorointestinal cancer. |
| Date of disclosure of the study information | 2015/03/26 |
| Last modified on | 2016/10/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Feasibility study about supportive therapy with elemental diet, "elental", for chemotherapy induced oral mucositis in patients with gastorointestinal cancer. | |
| Title of the study (Brief title) | KSCOG CR-05 | |
| Region |
|
|
| Condition | ||
| Condition | cancer chemotherapy induced oral mucositis | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Study about availability of nutritional therapy with elemental diet as supportive treatment against cancer chemotherapy induced oral mucositis or neutropenia. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | improvement of oral mucositis |
| Key secondary outcomes | change of oral intake
serological change frequency and degree of adverse event |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients received the same chemotherapy regimen as during the previous treatment in addition received more than 80 g of elemental diet "Elental" | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with colorectal cancer experiencing stomatitis(grade 1-3 on CTC-AE ver3.0) after a course of FOLFOX or FOLFIRI based chemotherapy
1)age over 20 years and under 80 years 2)Performance status(ECOG) 0 - 2 3)life expetancy > 3months 4)without serious disorder in hematopoietic,hepatic and renal function 5)written informed consent |
|||
| Key exclusion criteria | 1)cannot recovered from side effect of adjuvant chemotherapy
2)active infection 3)uncontrollable hypertention 4)uncontrollable diabete 5)clinically considerable cardiac disease 6)serious pulmonaly dissease 7)experience of clinically considerable psychological dysfunction or central nerve dysfunction 8)serious diarrhea 9)continuous systemic steroid treatment 10)pregnant women, nursing mother or women with childbearing intentions 11)participate in other clinical study 12)difficult to oral intake 13)physician judged inadequate for this study |
|||
| Target sample size | 36 | |||
| Research contact person | |
| Name of lead principal investigator | Yutaka Ogata |
| Organization | Kurume University |
| Division name | Department of surgery |
| Address | 155-1 Kokubu-machi, Kurume-shi 839-0863, Fukuoka JAPAN |
| TEL | 0942-22-6111 |
| yogata@med.kurume-u.ac.jp | |
| Public contact | |
| Name of contact person | Yutaka Ogata |
| Organization | Kurume University Medical Center |
| Division name | Department of surgery |
| Address | 155-1 Kokubu-machi, Kurume-shi 839-0863, Fukuoka JAPAN |
| TEL | 0942-22-6111 |
| Homepage URL | |
| yogata@med.kurume-u.ac.jp | |
| Sponsor | |
| Institute | Kurume University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | Ajinomoto Pharmaceuticals Co.,Inc. |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 久留米大学、久留米大学医療センター、くるめ病院、社会保険田川病院、公立八女総合病院、大牟田市立病院、済生会大牟田病院、久留米総合病院、朝倉医師会病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019637 |